老带新
h/m/r/p/cTGFb1 Q (1 Kit)
1/3

h/m/r/p/cTGFb1 Q (1 Kit)

分享
品牌: R&D Systems
pdf 下载产品说明书
pdf 下载SDS
用小程序,查商品更便捷
收藏
对比对比
咨询咨询
产品介绍
产品介绍
产品信息

Sample Values

Serum/Plasma/Urine - Samples were evaluated for the presence of TGF-beta 1 in this assay.

Human SamplesMean (pg/mL)Range (pg/mL)Standard Devitation (pg/mL)
Serum (n=31)51,64032,091-95,14711,901
platelet-poor EDTA plasma (n=31)23771414-4641729
Platelet-poor heparin plasma (n=31)23831445-3653561
Urine* (n=10)65.9ND-108---
*Only 40% of the urine samples meausered detectable levels (>31.3 pg/mL).
ND=Non-detectable

Mouse SamplesMean (pg/mL)Range (pg/mL)Standard Deviation (pg/mL)
Serum (n=10)97,35278,751-114,13012,623
Platelet-poor EDTA plasma (n=10)41,76316,577-68,50516,887
Platelet-poor heparin plasma (n=10)41,10118,195-66,70017,419

Rat SamplesMean (pg/mL)Range (pg/mL)Standard Deviation (pg/mL)
Serum (n=10)68,10843,721-89,13814,343
Platelet-poor EDTA plasma (n=5)58334912-78201141
Platelet-poor heparin plasma (n=5)13,9715274-26,1148392

Porcine SamplesMean (pg/mL)Range (pg/mL)Standard Deviation (pg/mL)
Serum (n=5)17,59713,481-23,9144146
Platelet-poor EDTA plasma (n=5)19551530-2810518
Platelet-poor heparin plasma (n=5)15671111-2475551

Canine SamplesMean (pg/mL)Range (pg/mL)Standard Deviation (pg/mL)
Serum (n=10)33,4552193-79,59019,795
Platelet-poor EDTA plasma** (n=5)2195ND-2515
Platelet-poor heparin plasma*** (n=5)3763ND-4278
**Only 60% of the EDTA plasma samples measured detectable levels with the required 40 fold dilution. Two of five samples read just below the standard curve (< 31.3 pg/mL).

***Only 80% of the heparin plasma samples measured detectable levels with the required 40 fold dilution. One of five samples read just below the standard curve (< 31.3 pg/mL).

 SAMPLE VALUES CONTINUED

Cell Culture Supernates:
Human peripheral blood mononuclear cells (PBMCs) were separated from whole blood by a density gradient centrifugation method using Ficoll-Paque Plus. CD4+ T cells were isolated from PBMCs using the MagCellect™ Human CD4+ T cell Isolation Kit (R&D Systems®, Catalog # MAGH102). Cells were seeded at 5 x 105 /mL and cultured using Excellerate™ Human T Cell Expansion Media, Xeno-Free (R&D Systems, Catalog # CCM030). T cells were left untreated or treated with 10 ng/mL GMP recombinant human (rh) IL-7 (R&D Systems, Catalog # 207-GMP), 10 ng/mL GMP rhIL-15 (R&D Systems, Catalog # 247-GMP), and stimulated via their T cell receptor (TCR) and co-stimulatory receptor for 5 days. TCR stimulation was mediated using 25 μL Cloudz™ CD3/28 particles (Cloudz T Cell Activation Kit - CD3/CD28, (R&D Systems, Catalog # CLD001) per mL of culture media. CD4+ T cells were maintained in a 5% CO2 incubator at 37 °C for 5 days. An aliquot of the cell culture supernates was removed, assayed for TGF-beta 1, and measured 77.7 pg/mL (untreated) and 471 pg/mL (treated).

Human PBMCs were seeded at 1 x 106 /mL and cultured in RPMI supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin and left untreated. An aliquot of the cell culture supernate was removed, assayed for TGF-beta 1, and measured 2854 pg/mL. 

Mouse EL-4 cells were cultured in DMEM High Glucose supplemented with 10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were then treated with 10 ng/mL PMA and 10 ug/mL PHA for 24 hours. An aliquot of the cell culture supernate was removed, assayed for TGF-beta 1, and measured 2969 pg/mL.

Rat spleen was taken from a pregnant Sprague Dawley rat, homogenized, and cultured in DME with 10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C and 5% CO2 . Rat splenocytes were treated with 50 ng/mL recombinant rat IL-2 and 5 μg/mL PHA for 3 days. An aliquot of the cell culture supernate was removed, assayed for TGF-beta 1, and measured 2716 pg/mL.

Porcine PK-15 cells were cultured in MEM supplemented with 10% FBS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin. Cells were treated with 1 μg/mL LPS for 72 hours. An aliquot of the cell culture supernate was removed, assayed for TGF-beta 1, and measured 1631 pg/mL. 






Precision

Intra-Assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision
Inter-Assay Precision (Precision between assays) Three samples of known concentration were tested in separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components

Cell Culture Supernates, Serum, Platelet-poor Plasma, Platelet-poor EDTA Plasma, Urine

Intra-Assay PrecisionInter-Assay Precision
Sample123456123456
n202020202020202020202020
Mean (pg/mL)3176831271309708107231265711843036221092
Standard Deviation11.342.231.115.34044.326.146.692.321.247.270
CV%3.66.22.455.64.18.47.17.877.66.4

Recovery

The recovery of TGF-beta 1 spiked to levels throughout the range of the assay in activated samples was evaluated.

Sample TypeAverage % RecoveryRange %
Media + FBS (n=4)10380-125
Platelet-poor EDTA Plasma (n=4)9083-98
Platelet-poor Plasma (n=4)9077-107
Serum-free Cell Culture Media (n=4)8782-95
Urine (n=4)114105-123

Linearity

To assess linearity of the assay, the activated samples containing and/or spiked with high concentrations of TGF-beta 1, were diluted with calibrator diluent to produce samples with values within the dynamic range of the assay.
Human TGF-beta 1 ELISA Linearity ELISA

Scientific Data

Human TGF-beta 1 ELISA Cell culture supernate/Urine Standard Curve

Human TGF-beta 1 ELISA Serum/Platelet-poor Plasma Standard Curve

Human/Mouse/Rat/Porcine/Canine TGF-beta 1 Quantikine ELISA Summary

Assay Length
4.5 hours
Sample Type & Volume Required Per Well
Cell Culture Supernates (50 uL), Serum (10 uL), Platelet-poor Plasma (50 uL), Platelet-poor EDTA Plasma (50 uL), Urine (50 uL)
Sensitivity
5.5 pg/mL
Assay Range
31.3 - 2,000 pg/mL (Cell Culture Supernates, Serum, Platelet-poor Plasma, Platelet-poor EDTA Plasma, Urine)
Specificity
Natural and recombinant TGF-beta 1. This assay also recognizes human TGF-beta 1.2.
Cross-reactivity
< 0.5% cross-reactivity observed with available related molecules.< 50% cross-species reactivity observed with species tested.
Interference
No significant interference observed with available related molecules.
背景
别名
CEDLAP,DPD1,latency-associated peptide,TGF beta,TGF beta1,TGFB,TGFB1,TGF-beta 1 protein,TGFbeta 1,TGF-beta 1,TGFbeta,TGF-beta-1,transforming growth factor beta-1,transforming growth factor, beta 1,Transforming Growth Factor beta 1
背景

Background: TGF-beta 1

Transforming Growth Factor Beta 1, 2, and 3 (TGF-beta 1, TGF-beta 2, and TGF-beta 3) are highly pleiotropic cytokines that virtually all cell types secrete. TGF-beta molecules are proposed to act as cellular switches that regulate processes such as immune function, proliferation, and epithelial-mesenchymal transition. Targeted deletions of these genes in mice show that each TGF-beta isoform has some non-redundant functions: TGF-beta 1 is involved in hematopoiesis and endothelial differentiation; TGF-beta 2 affects development of cardiac, lung, craniofacial, limb, eye, ear, and urogenital systems; and TGF-beta 3 influences palatogenesis and pulmonary development. The full range of in vitro biological activities of TGF-beta 5 has not yet been explored. However, TGF-beta 1, TGF-beta 2, TGF-beta 3, and TGF-beta 5 have been found to be largely interchangeable in an inhibitory bioassay, and it is anticipated that TGF-beta 5 will show a spectrum of activities similar to the other TGF-beta family members. To date, the production of TGF-beta 5 has only been demonstrated in Xenopus.

TGF-beta ligands are initially synthesized as precursor proteins that undergo proteolytic cleavage. The mature segments form active ligand dimers via a disulfide-rich core consisting of the characteristic 'cysteine knot'. TGF-beta signaling begins with binding to a complex of the accessory receptor betaglycan (also known as TGF-beta RIII) and a type II serine/threonine kinase receptor termed TGF-beta RII. This receptor then phosphorylates and activates a type I serine/threonine kinase receptor, either ALK-1 or TGF-beta RI (also called ALK-5). The activated type I receptor phosphorylates and activates Smad proteins that regulate transcription. Use of other signaling pathways that are Smad-independent allows for distinct actions observed in response to TGF-beta in different contexts.

Long Name:
Transforming Growth Factor beta 1
Entrez Gene IDs:
7040 (Human); 21803 (Mouse); 59086 (Rat); 397078 (Porcine); 100033900 (Equine)
Alternate Names:
CEDLAP; DPD1; latency-associated peptide; TGF beta; TGF beta1; TGFB; TGFB1; TGF-beta 1 protein; TGFbeta 1; TGF-beta 1; TGFbeta; TGF-beta-1; transforming growth factor beta-1; transforming growth factor, beta 1
声明 :本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。
货号:
DB100C
一键复制
询价
1Kit
1Pack
1Pack
选择数量
当前规格1件起购 
配送至
预计2-3周送达,快递: 免运费,若需干冰额外收费